SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
郑zhenglanyou
Lv1
1
70 积分
2023-06-22 加入
最近求助
最近应助
互助留言
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
2小时前
已完结
Optimizing Rectal Cancer Treatment: A Path Towards Personalization
2小时前
求助中
Improving individualised therapies in localised gastro-oesophageal adenocarcinoma
4天前
已完结
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
7天前
已完结
Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric cancer
10天前
已完结
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
10天前
已完结
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis
11天前
已完结
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
12天前
已完结
Tumour mutational burden: clinical utility, challenges and emerging improvements
16天前
已完结
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial
19天前
已完结
没有进行任何应助
速度真快,点赞
2小时前
帮大忙了,感谢
4天前
点赞,感谢
7天前
帮大忙了,感谢
10天前
速度真快,感谢
11天前
帮大忙了,速度真快
12天前
帮大忙了,感谢
16天前
帮大忙了,感谢
18天前
速度真快,感谢
20天前
找不到【积分已退回】
21天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论